Breaking Judge Orders Release of Immigrant Detainee Health Records to ACLU in Massachusetts Former Catholic Bishop Convicted of Sexual Abuse Trump Advocates for Permanent Daylight Saving Time Amidst Senate Uncertainty Kennedy Center Board Votes to Reinstate Trump Name, Citing Congressional Authority Phone Data Reveals Pre-Incident Searches in Massachusetts Murder Trial

Thursday August 13, 2026

Reporter

Acrivon Therapeutics, Inc

2Articles Published

5Communities Covered

Published Articles

Press Release

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts

Aug 12

Press Release

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Aug 5